UpFront Diagnostics Announces CE Mark Approval for LVOne — the World's First Rapid Blood Test to Diagnose Stroke

Contributed by: GlobeNewswire

Tags

medtech stroke

More Like This

Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care

PR Newswire associated0

Medtech Startup AI-Stroke Raises $4.6 Million to Bring Artificial Intelligence to Pre-CT Emergency Stroke Care

PR Newswire associated0

Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease

LifeArc and Global Alzheimer's Platform Foundation - Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer's disease before symptoms begin

PR Newswire associated0

A major advance on stroke at Montpellier University Hospital published in the New England Journal of Medicine

Advances in science set to transform treatments for people living with dementia

GlobeNewswire associated0

LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

PR Newswire associated0

Sysmex launches HISCL™ platform, enabling faster, scalable Alzheimer's blood testing